본문 바로가기
KERD
논문KCI 등재

기종성 신우신염의 임상양상 및 예후

Clinical Feature and Prognostic Factors of Emphysematous Pyelonephritis

1

조회

0

다운로드

2

인용

0

참고문헌

키워드

초록

Background: Emphysematous pyelonephritis (EPN) is a rare and potentially life-threatening condition that requires prompt evaluation and management. However, its clinical presentation and outcomes vary widely. This study was conducted to ascertain the clinical features and prognostic factors regarding EPN. Methods: All patients diagnosed with EPN radiologically and treated at the emergency department in the university- affiliated, tertiary-referral center, from January 1999 to December 2009 were evaluated. The patients’ demographic and clinical characteristics, computed tomographic findings, treatment, and outcomes were analyzed retrospectively. Results: Overall 14 patients diagnosed with EPN were admitted. There were 12 females and 2 males. A history of diabetes was found in 12 (85.7%) patients and was the most common comorbidity. The chief complaint among patients was flank pain (42.9%). Severe sepsis or septic shock was noted in 10 (71.4%) patients. Thirteen cases had unilateral involvement and one case had bilateral involvement. More than half of patients had Escherichia.coli in culture. Mean serum levels of HbA1c, creatinine, C-reactive protein (CRP) were 9.4 ± 2.7, 2.4 ± 1.4 mg/dl, and 22.4 ± 13.1 mg/dl. Eight (57.1%) patients received antibiotic treatment alone and four (28.6%) patients received the concurrent percutaneous drainage as well as antibiotics. Hospital mortality was 7.1%. A higher initial serum CRP level (20.3 vs. 49.8 mg/dl, p = 0.02) and HbA1c level (8.7 vs. 16.4, p = 0.01) was associated with hospital mortality. Conclusions: Antibiotics alone provide a high success rate for the treatment of EPN. Higher serum CRP and HbA1c level was associated with a higher mortality rate in patients with EPN.

Abstract

Background: Emphysematous pyelonephritis (EPN) is a rare and potentially life-threatening condition that requires prompt evaluation and management. However, its clinical presentation and outcomes vary widely. This study was conducted to ascertain the clinical features and prognostic factors regarding EPN. Methods: All patients diagnosed with EPN radiologically and treated at the emergency department in the university- affiliated, tertiary-referral center, from January 1999 to December 2009 were evaluated. The patients’ demographic and clinical characteristics, computed tomographic findings, treatment, and outcomes were analyzed retrospectively. Results: Overall 14 patients diagnosed with EPN were admitted. There were 12 females and 2 males. A history of diabetes was found in 12 (85.7%) patients and was the most common comorbidity. The chief complaint among patients was flank pain (42.9%). Severe sepsis or septic shock was noted in 10 (71.4%) patients. Thirteen cases had unilateral involvement and one case had bilateral involvement. More than half of patients had Escherichia.coli in culture. Mean serum levels of HbA1c, creatinine, C-reactive protein (CRP) were 9.4 ± 2.7, 2.4 ± 1.4 mg/dl, and 22.4 ± 13.1 mg/dl. Eight (57.1%) patients received antibiotic treatment alone and four (28.6%) patients received the concurrent percutaneous drainage as well as antibiotics. Hospital mortality was 7.1%. A higher initial serum CRP level (20.3 vs. 49.8 mg/dl, p = 0.02) and HbA1c level (8.7 vs. 16.4, p = 0.01) was associated with hospital mortality. Conclusions: Antibiotics alone provide a high success rate for the treatment of EPN. Higher serum CRP and HbA1c level was associated with a higher mortality rate in patients with EPN.

참고문헌 (18)

  1. Michaeli J, "Emphysematous pyelonephritis", J Urol, 131, pp.203~208 (1984)
  2. Huang JJ, "Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis", Arch Intern Med, 160, pp.797~805 (2000)
  3. Tang HJ, "Clinical characteristics of emphysematous pyelonephritis", J Microbiol Immunol Infect, 34, pp.125~130 (2001)
  4. Modi P, "Scrotal extension of emphysematous pyelonephritis", Int Urol Nephrol, 39, pp.405~407 (2007)
  5. Baliga KV, "Successful medical treatment of emphysematous pyelonephritis in a renal allograft recipient", Ren Fail, 29, pp.755~758 (2007)
  6. Ahlering TE, "Emphysematous pyelonephritis: a 5-year experience with 13 patients", J Urol, 134, pp.1086~1088 (1985)
  7. 이동주, "Pelvis에 생긴 Gas Pattern을 보이는 기종성 신우신염의 내과적 치험 1예", Kidney Research and Clinical Practice, 20(2), pp.319~322 (2001), 대한신장학회
  8. Ramanathan V, "Successful medical management of recurrent emphysematous pyelonephritis", Urology, 623, pp.e11~e13 (2006)
  9. Somani BK, "Is percutaneous drainage the new gold standard in the management of emphysematous pyelonephritis? Evidence from a systematic review", J Urol, 179, pp.1844~1849 (2008)
  10. 조수연, "기종성 신우신염의 임상양상 및 사망위험인자", Infection and Chemotherapy, 41(1), pp.30~35 (2009), 대한감염학회
  11. Kuo CY, "Clinical features and prognostic factors of emphysematous urinary tract infection", J Microbiol Immunol Infect, 42, pp.393~400 (2009)
  12. Yang WH, "Gas-forming infection of the urinary tract: an investigation of fermentation as a mechanism", J Urol, 143, pp.960~964 (1990)
  13. Shokeir AA, "Emphysematous pyelonephritis: a 15-year experience with 20 cases", Urology, 49, pp.343~346 (1997)
  14. Pontin AR, "Current management of emphysematous pyelonephritis", Nat Rev Urol, 6, pp.272~279 (2009)
  15. Kapoor R, "Predictive factors for mortality and need for nephrectomy in patients with emphysematous pyelonephritis", BJU Int, 105, pp.986~989 (2010)
  16. Khaira A, "Retrospective analysis of clinical profile prognostic factors and outcomes of 19 patients of emphysematous pyelonephritis", Int Urol Nephrol, 41, pp.959~966 (2009)
  17. Lin YC, "Risk factors of renal failure and severe complications in patients with emphysematous pyelonephritis-a single-center 15-year experience", Am J Med Sci, 343, pp.186~191 (2012)
  18. 송필현, "기종성 신우신염 24례의 최고 전략 분석", Infection and Chemotherapy, 43(4), pp.339~342 (2011), 대한감염학회

관련 논문AI추천

기종성 신우신염의 임상양상 및 사망위험인자이승주, 이호재, 조수연, 조용현대한감염학회 · Infection and Chemotherapy2009 · 제41권 제1호기종성 신우신염 24례의 최고 전략 분석김현태, 송필현대한감염학회 · Infection and Chemotherapy2011 · 제43권 제4호당뇨병 환자에서 발생한 기종성 신우신염 1례김영수, 원규장, 윤경우, 윤현대, 이찬우, 이헌주, 이현우, 이형우, 조인호, 조철규영남대학교 의과대학 · Journal of Yeungnam Medical Science1993 · 제10권 제2호Mortality and Risk Factors for Emphysematous Pyelonephritis in Korea: A Multicenter Retrospective Cohort StudyEu Chang Hwang, Hong Chung, Jae Hung Jung, Jae Min Chung, Jeong Woo Lee, Jin Bong Choi, Joongwon Choi, Ju-Hyun Shin, Jung Sik Huh, Sangrak Bae, Seung Il Jung, Seung-Kwon Choi, Tae-Hyoung Kim, Woong Bin Kim, Yeonjoo Kim대한요로생식기감염학회 · Urogenital Tract Infection2025 · 제20권 제1호Characteristics and Treatment Trends for Emphysematous Pyelonephritis in Korea: A 10-Year Multicenter Retrospective Study정홍, 김웅빈, 김태형, 배상락, 유구한, 정재흥, 최진봉, Eu Chang Hwang, Jae Min Chung, Jeong Woo Lee, Joongwon Choi, Ju-Hyun Shin, Jung-Sik Huh, Seung Il Jung, 최승권(Seung-Kwon Choi), Yeonjoo Kim대한요로생식기감염학회 · Urogenital Tract Infection2021 · 제16권 제2호복부 Computed Tomography 촬영을 통해 기종성 신우신염으로 발견된 의식 변화 환자김지혜, 문연숙, 백진휘, 정현민, 한승백대한요로생식기감염학회 · Urogenital Tract Infection2014 · 제9권 제1호

이 간행물의 다른 논문 (14건)